Shashi Srinivasan, MD
Dermatology · Salem, ORNPI 1992755813
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 336 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 37.6% of the total.
Across 336 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$826
- Sun Pharmaceutical Industries Inc.$383
- Pfizer$338
- E.r. Squibb & Sons, L.L.C.$296
- Sanofi$290
- plus $2K from 23 others
What the payments were for
- Food & beverage$6,56596%
- Education$2714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 141 | $2,568 |
| Johnson & Johnson | 38 | $826 |
| Sun Pharmaceutical Industries Inc. | 11 | $383 |
| Pfizer | 19 | $338 |
| E.r. Squibb & Sons, L.L.C. | 20 | $296 |
| Sanofi | 12 | $290 |
| Regeneron Healthcare Solutions, Inc. | 10 | $279 |
| Amgen | 11 | $261 |
| Arcutis Biotherapeutics, Inc. | 11 | $187 |
| Novartis | 7 | $178 |
| Lilly USA, LLC | 6 | $135 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $126 |
| Dermavant Sciences, Inc. | 5 | $109 |
| UCB, Inc. | 5 | $107 |
| Incyte Corporation | 4 | $92 |
| LEO Pharma Inc. | 4 | $91 |
| Boehringer Ingelheim | 4 | $89 |
| Organon | 3 | $79 |
| Galderma Laboratories, L.p. | 4 | $75 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $72 |
| Mallinckrodt Hospital Products Inc. | 2 | $57 |
| Elekta, Inc. | 1 | $52 |
| Medtronic | 2 | $28 |
| Biocon Biologics Inc | 1 | $24 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Biowound Solutions, Inc. | 1 | $20 |
| Mylan Institutional Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$6,836 in reported general payments places this provider in the 80th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 15 | $307,278 |
| Dupixent SyringeDupilumab | 12 | $44,313 |
| Fluorouracil | 91 | $5,540 |
| Clindamycin Phosphate | 122 | $5,193 |
| Calcipotriene | 39 | $3,332 |
| Triamcinolone Acetonide | 227 | $2,473 |
| Doxycycline Hyclate | 102 | $2,404 |
| Tacrolimus | 20 | $2,372 |
| Metronidazole | 37 | $2,307 |
| Clobetasol Propionate | 62 | $1,846 |
| Betamethasone Dipropionate | 29 | $1,504 |
| Fluocinonide | 40 | $1,153 |
| Fluocinolone Acetonide | 22 | $821 |
| Mometasone Furoate | 50 | $690 |
| Minocycline Hcl | 38 | $631 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Salem
- Karsten JohnsonSalem$11K
- Paarth DodiaSalem$11K
- Patrick WhitmanSalem$9K
- Lacey RoybalSalem$9K
- Russell YoungSalem$8K
- Preston ChadwickSalem$8K
- Michael GoodenbergerSalem$6K
- Reyna SwiftSalem$5K
- Erik KokkonenSalem$5K
- Joshua BezecnySalem$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.